LLLT stands for low-level laser therapy, a treatment that uses red or near-infrared light to reduce pain, decrease inflammation, and promote tissue healing. Unlike surgical or cosmetic lasers that cut or burn, LLLT delivers light at low power levels that don’t heat your tissue. The therapy has been used clinically for over 40 years, and the field is gradually shifting toward a newer, more accurate name: photobiomodulation therapy, or PBM.
Why the Name Is Changing
The term “low-level laser therapy” has always been a bit imprecise. “Low” and “level” are vague, and “laser” no longer covers the full range of devices used. Many modern devices rely on LEDs or broadband light sources rather than true lasers. A consensus among researchers now favors “photobiomodulation therapy,” defined as a form of light therapy using non-ionizing light sources (lasers, LEDs, or broadband light) in the visible and infrared spectrum. The key distinction is that it’s nonthermal: the therapeutic effect comes from a chemical reaction in your cells, not from warming the tissue. You’ll still see “LLLT” everywhere because it remains the official search term in the National Library of Medicine’s database, but expect to encounter “PBM” more often in newer products and research.
How Light Triggers Healing at the Cellular Level
The core mechanism involves your mitochondria, the energy-producing structures inside nearly every cell. A specific enzyme at the end of the mitochondrial energy chain acts as the primary light absorber. When red or near-infrared light reaches this enzyme, it speeds up electron transport, which increases the rate at which your cells produce ATP, their main energy currency.
This boost in cellular energy has a cascade of downstream effects. As the enzyme works harder, it consumes more oxygen, which triggers increased blood flow to the treated area. More oxygenated blood arrives to meet the demand. The result is reduced inflammation, faster tissue repair, and pain relief. It’s not a thermal process. Your skin doesn’t warm up meaningfully during treatment, which is why LLLT is sometimes called “cold laser” therapy.
Wavelengths and Tissue Depth
Not all light penetrates equally. Visible red light at around 660 nanometers is readily absorbed by blood and skin, limiting its penetration to less than 10 millimeters. That makes it well suited for skin conditions, superficial wounds, and hair follicle stimulation. Near-infrared light at around 810 nanometers passes through surface tissue much more easily, reaching depths of 30 to 40 millimeters or more. This deeper penetration is why near-infrared wavelengths are preferred for joint pain, muscle injuries, and brain-related applications.
Lasers vs. LEDs
One of the most common points of confusion is whether you need a true laser or whether an LED device works just as well. The short answer: it depends on how deep you need the light to go.
Laser light is coherent and collimated, meaning the light waves travel in sync and in a tight beam. When this beam enters tissue, it creates tiny interference patterns called “speckles” that are roughly the same size as mitochondria. One theory suggests these speckles are particularly effective at stimulating cellular energy production. LED light, by contrast, is non-coherent and spreads out quickly.
For surface-level treatments like acne, wound healing, or skin rejuvenation, LEDs perform comparably to lasers in clinical studies. Some animal and human trials have even found LEDs slightly more effective for specific superficial applications, such as reducing wound size in diabetic skin or alleviating pain from orthodontic treatment. But for deeper targets, lasers consistently outperform LEDs. If you’re treating a joint, a deep muscle, or the brain through the skull, laser-based devices offer a meaningful advantage in penetration.
What LLLT Treats
The strongest clinical evidence supports LLLT for musculoskeletal pain. It has FDA clearance for temporary relief of muscle and joint pain and has been shown to reduce inflammation and swelling, relieve pain, and promote healing across a range of conditions. It’s effective for both standard tissue pain and nerve-related pain, though it hasn’t yet been proven helpful for centralized pain conditions where the nervous system itself is the source.
Hair loss is the other major application with solid evidence. The FDA has cleared several over-the-counter laser cap devices specifically for androgenetic alopecia (pattern hair loss) in both men and women. Clinical trials consistently show meaningful hair density increases. In one controlled study, participants using LLLT gained about 19.8 hairs per square centimeter while the sham group lost 7.6. Another found gains of 17.2 hairs per square centimeter versus a loss of 2.1 in controls. When LLLT is combined with minoxidil, results tend to be better than minoxidil alone: one trial reported a 78.3% improvement rate in the combination group compared to 51.3% with minoxidil only. These are real, measurable improvements, though no study has shown dramatic regrowth exceeding 50% from baseline.
Other applications with varying levels of evidence include wound healing, oral mucositis (mouth sores from cancer treatment), tendon injuries, and nerve regeneration. LLLT is generally used as a complementary therapy alongside other treatments rather than as a standalone cure.
What a Treatment Session Looks Like
A typical clinical course involves 10 to 20 sessions scheduled two to three times per week over six to eight weeks, with several days between sessions to allow tissue recovery. Individual treatment points often receive light for about 60 seconds each, though total session time varies depending on the size of the area being treated. You won’t feel heat or pain during the session. Most people feel nothing at all, though some report a mild tingling sensation.
Home-use devices, particularly laser caps for hair loss, follow a different pattern. These are typically used for 20 to 30 minutes every other day over several months. Both prescription and over-the-counter versions exist, and both are designed for home use with the same intended purpose.
Device Power and Safety Classes
Clinical LLLT devices generally fall into two categories. Class 3B lasers are limited to a maximum power of 0.5 watts and require protective eyewear, key switches, and safety interlocks. Class 4 lasers exceed that threshold, with some therapy devices reaching up to 15 watts. Class 4 devices also require eye protection against both direct and reflected light. Higher power doesn’t automatically mean better results. It means the light can deliver energy to deeper tissue faster, but it also increases the risk of overexposure if used incorrectly.
Home devices are typically lower-powered and designed to be safe for unsupervised use. The FDA clears these through the 510(k) pathway, which requires manufacturers to demonstrate the device is substantially similar to an already-approved product.
Safety Considerations
LLLT is considered low-risk for most people, but there are specific situations where caution is warranted. Even though the light is non-ionizing and nonthermal, it can trigger changes in secretory tissues like the thyroid gland, so people with thyroid disease are typically excluded from treatment near the neck. Other standard exclusions include pregnancy, active cancer in the treatment area, and a history of keloid scarring.
Eye safety is the most important practical concern. Direct exposure to laser light can damage the retina, and even LED devices have caused retinal injury in reported cases involving prolonged use of home face masks. Protective eyewear appropriate to the wavelength being used is essential for any device above Class 2.